3//SEC Filing
ADAR1 Partners, LP 3
Accession 0001940272-24-000004
CIK 0001444192other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 8:29 PM ET
Size
6.7 KB
Accession
0001940272-24-000004
Insider Transaction Report
Form 3
ADAR1 Partners, LP
10% Owner
Holdings
- 959,571(indirect: By: ADAR1 Partners)
Class A Common Stock
ADAR1 Capital Management, LLC
10% Owner
Holdings
- 959,571(indirect: By: ADAR1 Partners)
Class A Common Stock
Footnotes (3)
- [F1]ADAR1 Capital Management GP, LLC is the general partner of ADAR1 Partners, LP ("ADAR1 Partners").
- [F2]ADAR1 Capital Management, LLC ("ADAR1 Capital"), an entity owned and controlled by Dr. Daniel Schneeberger, owns voting and investment control with respect to the shares held by ADAR1 Partners, LP. Because of the relationship between ADAR1 Partners and ADAR1 Capital, ADAR1 Capital may be deemed to beneficially own the shares held directly by ADAR1 Partners.
- [F3]For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
Documents
Issuer
Acasti Pharma Inc.
CIK 0001444192
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001758866
Filing Metadata
- Form type
- 3
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 8:29 PM ET
- Size
- 6.7 KB